Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Methotrexate | FIMM | pan-cancer | AAC | 0.046 | 0.7 |
mRNA | NU-7441 | GDSC1000 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | CEP-701 | FIMM | pan-cancer | AAC | -0.04 | 0.7 |
mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | VX-702 | GDSC1000 | pan-cancer | AAC | 0.012 | 0.8 |
mRNA | etoposide | GDSC1000 | pan-cancer | AAC | 0.012 | 0.8 |
mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.8 |
mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.8 |